Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder? (2022)
Attributed to:
Manchester – Confidence in Concept 2019
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/ijms23094854
PubMed Identifier: 35563245
Publication URI: http://europepmc.org/abstract/MED/35563245
Type: Journal Article/Review
Volume: 23
Parent Publication: International journal of molecular sciences
Issue: 9
ISSN: 1422-0067